Tagged glioblastoma

Press Release

Glioblastoma Foundation® Announces the Establishment of Groundbreaking Genomic Testing & Research Laboratory

 Read More
Press Release

Glioblastoma Foundation to Be Official Charity Partner of the 2024 Los Angeles Marathon

LA Marathon Runners Take on 26.2 Miles to Support the Glioblastoma Foundation.

 Read More
Glioblastoma Foundation Hosts ‘Rock Against Glioblastoma’ (RAG), Shining a Spotlight on Deadliest Form of Brain Cancer
Press Release

Glioblastoma Foundation Hosts ‘Rock Against Glioblastoma’ (RAG), Shining a Spotlight on Deadliest Form of Brain Cancer

First Annual Music Festival Features Talented Lineup of Performers at the Legendary Cat’s Cradle, Raising Vital Funds for Glioblastoma Research & Treatment

 Read More
Gibson Oncology Expands Its Board of Directors With Accomplished Leadership in Oncology Clinical Development and Corporate Strategy
Press Release

Gibson Oncology Expands Its Board of Directors With Accomplished Leadership in Oncology Clinical Development and Corporate Strategy

 Read More
The Voice Finalist Morgan Myles Joins the Glioblastoma Foundation® as a Celebrity Ambassador to Raise Awareness and Funding for Glioblastoma
Press Release

The Voice Finalist Morgan Myles Joins the Glioblastoma Foundation® as a Celebrity Ambassador to Raise Awareness and Funding for Glioblastoma

The Glioblastoma Foundation® launched a new awareness campaign today featuring Morgan Myles as the celebrity ambassador with the goal of raising awareness of Glioblastoma — the most lethal and common form of brain cancer.

 Read More
TVAX Biomedical Announces Receipt of $2 Million FDA Orphan Products Grant for Glioblastoma Study
Press Release

TVAX Biomedical Announces Receipt of $2 Million FDA Orphan Products Grant for Glioblastoma Study

 Read More
Philogen Announces Publication of Malignant Brain Tumor Study Results in Science Translational Medicine
Press Release

Philogen Announces Publication of Malignant Brain Tumor Study Results in Science Translational Medicine

(i) Study shows Philogen's proprietary immunocytokines are effective treatment for brain tumors.
(ii) Early promising findings from Philogen's Phase I/II study investigating the safety and efficacy of L19TNF monotherapy in patients with glioblastoma.
(iii) Philogen's proprietary cancer treatment found to be safe and well-tolerated.

 Read More
Press Release

Live Like Bella® Approves Grant to Aurora Biopharma to Include Children in Their Immunotherapy Trials

Live Like Bella® founded in 2013 has approved a grant to Aurora Biopharma to admit children for the first time into their cutting-edge Immunotherapy research. This is incredible news for the Cancer Community and especially children suffering with the very deadly forms of cancer known as Glioblastoma (Brain Cancer) and Osteocracoma (Bone Cancer) .

Read More